Indian Council of Medical Research-National Institute of Cholera and Enteric Diseases, Kolkata, India.
Indian Council of Medical Research-National Institute of Epidemiology, Chennai, India.
PLoS Negl Trop Dis. 2024 Sep 3;18(9):e0012450. doi: 10.1371/journal.pntd.0012450. eCollection 2024 Sep.
Indian subcontinent being an important region in the fight to eliminate cholera needs better cholera surveillance. Current methods miss most infections, skewing disease burden estimates. Triangulating serosurvey data, clinical cases, and risk factors could reveal India's true cholera risk.
We synthesized data from a nationally representative serosurvey, outbreak reports and risk factors like water, sanitation and the Multidimensional Poverty Index, to create a composite vulnerability index for assessing state-wise cholera risk in India. We tested 7,882 stored sera samples collected during 2017-18 from individuals aged 9-45 years, for vibriocidal antibodies to Vibrio cholerae O1 using a cut-off titre ≥320 defining as elevated titre. We also extracted data from the 2015-19 Integrated Disease Surveillance Programme and published cholera reports.
Overall, 11.7% (CI: 10.4-13.3%) of the sampled population had an elevated titre of cholera vibriocidal antibodies (≥320). The Southern region experienced the highest incidence (16.8%, CI: 12.1-22.8), followed by the West (13.2%, CI: 10.0-17.3) and North (10.7%, CI: 9.3-12.3). Proportion of samples with an elevated vibriocidal titre (≥320) was significantly higher among individuals aged 18-45 years (13.0% CI: 11.2-15.1) compared to children 9-17 years (8.6%, CI 7.3-10.0, p<0.05); we found no differences between sex or urbanicity. Between 2015-2019, the Integrated Disease Surveillance Program (IDSP) reported 29,400 cases of cholera across the country. Using the composite vulnerability index, we found Karnataka, Madhya Pradesh, and West Bengal were the most vulnerable states in India in terms of risk of cholera.
The present study showed that cholera infection is present in all five regions across India. The states with high cholera vulnerability could be prioritized for targeted prevention interventions.
印度次大陆是消除霍乱的重要地区,需要更好的霍乱监测。目前的方法错过了大多数感染,从而扭曲了疾病负担的估计。三角测量血清调查数据、临床病例和风险因素,可以揭示印度真正的霍乱风险。
我们综合了全国代表性血清调查、疫情报告以及水、卫生和多维贫困指数等风险因素的数据,为评估印度各邦的霍乱风险创建了一个综合脆弱性指数。我们测试了 7882 个在 2017-18 年期间从 9-45 岁个体中收集的储存血清样本,使用定义为高滴度的 ≥320 作为截定点,检测对霍乱弧菌 O1 的杀菌抗体。我们还从 2015-19 年综合疾病监测计划和已发表的霍乱报告中提取了数据。
总体而言,抽样人群中有 11.7%(95%置信区间:10.4-13.3%)的人对霍乱杀菌抗体有高滴度(≥320)。南部地区的发病率最高(16.8%,95%置信区间:12.1-22.8),其次是西部(13.2%,95%置信区间:10.0-17.3)和北部(10.7%,95%置信区间:9.3-12.3)。18-45 岁年龄组(13.0%,95%置信区间:11.2-15.1)的个体与 9-17 岁儿童(8.6%,95%置信区间:7.3-10.0)相比,血清样本中有高杀菌抗体滴度(≥320)的比例显著更高(p<0.05);我们没有发现性别或城市与农村之间的差异。2015-2019 年期间,综合疾病监测计划报告了全国范围内 29400 例霍乱病例。使用综合脆弱性指数,我们发现卡纳塔克邦、中央邦和西孟加拉邦是印度最易发生霍乱的邦。
本研究表明,霍乱感染存在于印度五个地区。高霍乱脆弱性的州可以优先考虑有针对性的预防干预措施。